Cargando…

Development of Schamberg's disease after SARS‐CoV‐2 vaccination

Schamberg's disease is one of a group of pigmented purpura diseases. We report a 43‐year‐old woman, who developed Schamberg’s disease after SARS‐CoV‐2 vaccination. Three days after vaccination, a purpuric eruption occurred on the lower extremities, extending to the buttocks, and subsided in 4 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Morimoto, Hiroki, Ogura, Yasuaki, Otsuka, Masaki, Hayano, Satoshi, Tokura, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347743/
http://dx.doi.org/10.1002/cia2.12247
_version_ 1784761876626800640
author Morimoto, Hiroki
Ogura, Yasuaki
Otsuka, Masaki
Hayano, Satoshi
Tokura, Yoshiki
author_facet Morimoto, Hiroki
Ogura, Yasuaki
Otsuka, Masaki
Hayano, Satoshi
Tokura, Yoshiki
author_sort Morimoto, Hiroki
collection PubMed
description Schamberg's disease is one of a group of pigmented purpura diseases. We report a 43‐year‐old woman, who developed Schamberg’s disease after SARS‐CoV‐2 vaccination. Three days after vaccination, a purpuric eruption occurred on the lower extremities, extending to the buttocks, and subsided in 4 weeks. No recurrence was observed thereafter. It is suggested that the vaccination triggered the development of the eruption, which was not merely coincidental. SARS‐CoV‐2 vaccination may stimulate a certain population of T cells, resulting in the development of pigmented purpuric dermatoses.[Image: see text]
format Online
Article
Text
id pubmed-9347743
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93477432022-08-03 Development of Schamberg's disease after SARS‐CoV‐2 vaccination Morimoto, Hiroki Ogura, Yasuaki Otsuka, Masaki Hayano, Satoshi Tokura, Yoshiki Journal of Cutaneous Immunology and Allergy Correspondences Schamberg's disease is one of a group of pigmented purpura diseases. We report a 43‐year‐old woman, who developed Schamberg’s disease after SARS‐CoV‐2 vaccination. Three days after vaccination, a purpuric eruption occurred on the lower extremities, extending to the buttocks, and subsided in 4 weeks. No recurrence was observed thereafter. It is suggested that the vaccination triggered the development of the eruption, which was not merely coincidental. SARS‐CoV‐2 vaccination may stimulate a certain population of T cells, resulting in the development of pigmented purpuric dermatoses.[Image: see text] John Wiley and Sons Inc. 2022-05-12 /pmc/articles/PMC9347743/ http://dx.doi.org/10.1002/cia2.12247 Text en © 2022 The Authors. Journal of Cutaneous Immunology and Allergy published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society for Cutaneous Immunology and Allergy https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Correspondences
Morimoto, Hiroki
Ogura, Yasuaki
Otsuka, Masaki
Hayano, Satoshi
Tokura, Yoshiki
Development of Schamberg's disease after SARS‐CoV‐2 vaccination
title Development of Schamberg's disease after SARS‐CoV‐2 vaccination
title_full Development of Schamberg's disease after SARS‐CoV‐2 vaccination
title_fullStr Development of Schamberg's disease after SARS‐CoV‐2 vaccination
title_full_unstemmed Development of Schamberg's disease after SARS‐CoV‐2 vaccination
title_short Development of Schamberg's disease after SARS‐CoV‐2 vaccination
title_sort development of schamberg's disease after sars‐cov‐2 vaccination
topic Correspondences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347743/
http://dx.doi.org/10.1002/cia2.12247
work_keys_str_mv AT morimotohiroki developmentofschambergsdiseaseaftersarscov2vaccination
AT ogurayasuaki developmentofschambergsdiseaseaftersarscov2vaccination
AT otsukamasaki developmentofschambergsdiseaseaftersarscov2vaccination
AT hayanosatoshi developmentofschambergsdiseaseaftersarscov2vaccination
AT tokurayoshiki developmentofschambergsdiseaseaftersarscov2vaccination